It was shown previously that the distribution of the Pathologische Anatomie Leiden-Endothelium (PAL-E) antigen [13] in brain and eye is restricted to sites where no barrier function is present, e. g. dura, choroid plexus, area postrema and choroid, and to pathological conditions characterized by absence of a barrier as in primary and metastatic brain tumours [14±17] . In other parts of the brain and eye where the blood-tissue barriers are present, this endothelium-specific antigen is absent [14±17]. At the electron microscopic level the antigen is associated with the plasmalemmal vesicles (caveolae) of endothelial cells [13, 18] . These caveolae have a function in transcellular transport and are scare in the endothelium in areas with a blood-tissue barrier [19±22] . The PAL-E antigen therefore may have a function in non-specific trancellular transport [13±17] .We did an immunohistochemical study in eye tissues from diabetic patients and normal control subjects to test the hypotheses that 1) the PAL-E antigen is involved in vascular permeability, 2) that endothelial PAL-E staining may indicate barrier loss in pre-existent vessels in the retina and 3) that vascular leakage in diabetic retinopathy involves endothelial cellular changes.
Materials and methods
Tissue samples. The investigations were done in accordance with the principles of the Declaration of Helsinki. Human eyes from 30 donors (age range 28 to 88 years, mean 70 years) with no known history of diabetes mellitus were kindly provided by the Corneabank Amsterdam, In addition, eyes of 41 people with known diabetes mellitus (age range 48 to 90 years, mean 75 years) were obtained from the Corneabank Amsterdam (n = 31) or enucleated at autopsy at the Department of Pathology, Academic Medical Centre, Amsterdam (n = 10). The cause of death of the cornea donors was known, but for reasons of privacy information on the type of diabetes and the history of eye disease, in particular of the posterior segment, was unavailable. Relevant clinical data of the autopsy patients are listed in Table 1 . The ophthalmological history was available for five of these patients and for two a fluorescein angiogram (FA) was available. Whole eyes were snap-frozen in isopenthane within 3 to 28 h (mean 16 h; diabetic patients) and 5 to 36 h (mean 19 h; control subjects) after death of the donor. In all cases identical samples of the posterior segment were dissected and stored at ±70°C.
Immunoperoxidase staining. Cryo-sections of samples were air-dried, fixed with acetone for 10 min and postfixed with Zamboni fixative (2 % paraformaldehyde in a saturated picric acid solution). Serial sections were stained by an indirect immunoperoxidase procedure with the following antibodies: monoclonal antibodies (mAbs) PAL-E (Pathologische Anatomie Leiden-Endothelium) [13] and the general endothelial marker mAb EN-4 (anti-CD 31) (Mon 6002, Sanbio, Uden, The Netherlands) [18] . To analyse vascular leakage, sections were stained with a MoAb reactive with human fibrinogen (kindly provided by Dr. J. J. Emeis from the Gaubius Laboratoriurn TNO/PG, Leiden, The Netherlands) [23] , an antibody reactive with human IgG (polyclonal goat anti-human IgG conjugated to horseradish peroxidase) and a rabbit polyclonal antibody reactive with human albumin (DAKO, Copenhagen, Denmark) [5±9, 24] . All antibodies were used at appropriate dilutions and goat anti-mouse IgG and swine anti-rabbit IgG conjugated to horseradish peroxidase (DAKO, Copenhagen, Denmark) were used as secondary antibodies. For staining, incubation for 10 min in 3-amino-9-ethylcarbazole containing [25] . In negative control sections the first antibodies were omitted. Counterstaining was done with haematoxylin. All sections were examined by two independent observers and scored blind. Distribution of the staining product and intensity of staining were assessed for all antibodies. Distribution of retinal vascular staining for PAL-E and fibrinogen was graded semi-quantitatively as follows: 0, no staining; 1, sporadic staining (less than three positive capillaries per 5 mm section); 2, patchy staining (localized areas with staining capillaries, but less than 50 % of vessels positive); or 3, uniform staining (more than 50 % of vessels positive). For the correlation between the two ordinal variables PAL-E staining and fibrinogen staining, we used the conventional non-parametric rank-order gamma-test, which can be interpreted as a correlation coefficient (SPSS version 8.0, section Crosstabs, SPSS Inc., USA) [26] . , but absent staining of the capillaries in the normal retina for PAL-E (D), anti-fibrinogen (F), and anti-IgG (H). In the retina of the diabetic patient, staining with anti-fibrinogen (E), and anti-IgG (G) indicates leaking capillaries, which are also stained for PAL-E (C) (capillaries indicated by arrows; C = choroid). Note the diffuse stromal staining in the choroid for fibrinogen and IgG and staining of the choroidal vasculature by anti-PAL-E in both sections (C±D), (staining indicated by asterisks) (´120)
Results
Of the retinas of donors with diabetes mellitus, 17 of 41 showed pronounced microvascular staining with PAL-E in a patchy or uniform distribution whereas in 8 a weak or pronounced sporadic staining of retinal capillaries was observed ( Fig. 1C and 2C ). The PAL-E positive vessels, localized in both the superficial and deep inner retina, were often larger than vessels in normal retinas. In some instances, the endothelium of a large retinal vessel was stained at the side facing the neuroretina (results not shown). Four of the PAL-E positive eyes showed microaneurysms or hard exudates or both (Fig. 2D) , exclusively observed in the PAL-E positive areas. In serial sections, staining for PAL-E was compared with sections stained with anti-fibrinogen (all eyes), anti-IgG (in ten diabetic and ten control eyes), anti-albumin (in ten diabetic and ten control eyes) and the pan-endothelial marker EN-4 (CD 31) (all eyes). Staining for CD31 was observed in all retinal vessels in both control and diabetic eyes, and this enabled grading of the extent of vascular staining of PAL-E and anti-fibrinogen. Staining for endogenous fibrinogen was patchy or uniform in the retina of 14 out of 41 diabetic eyes and sporadic in 9. Reaction product was confined to the microvascular walls and did usually not extend to the perivascular area (Figs.  1B and 2D) . In almost all eyes, serial sections indicated that positive staining for fibrinogen and PAL-E colocalized in the same microvessels in corresponding areas (Figs. 1 and 2) ( Table 2 ). This correlation was high for the two groups combined (gamma = 0.753, p < 0.001). In the ten diabetic patients studied, staining for IgG and albumin was also observed in the areas with PAL-E positive vessels, both in the vascular walls and in a more diffuse pattern (Fig. 1G) .
In a small number of the donors and autopsy patients, clinical information was available about the presence and degree of diabetic retinopathy or other diabetic complications (summarized for the autopsy patients in Table 1 ). One donor with uniform pronounced PAL-E staining had been treated with laser for proliferative diabetic retinopathy. Another patient with uniform marked PAL-E staining (autopsy patient 10, Table 1 ) suffered clinically from diabetic retinopathy with a fundus picture of scattered dot haemorrhages, a few hard exudates and microaneurysms. Focal leakage in the posterior pole of this eye was shown by fluorescein angiography (FA) carried out 6 months before death. In addition to the pronounced PAL-E staining within the retina, this eye histologically showed proliferative retinopathy with preretinal neovascularization consisting of PAL-E positive capillaries (results not shown). Another diabetic patient with a patchy distribution of PAL-E staining (autopsy patient 7) had early background diabetic retinopathy 4 years before death, with a few scattered microaneurysms and minimal leakage shown by FA (Table 1 ) (results not shown).
In 21 out of 30 control eyes, retinal capillaries were completely negative for PAL-E (Figs. 1D and 2A ), but in 7 eyes sporadic, and in 2 eyes a patchy staining was observed (Table 2 ). In all of these eyes staining intensity was weak. Sporadic staining for fibrinogen was observed in eight normal eyes and in two eyes a patchy distribution was seen. In these ten eyes fibrinogen staining intensity was weak and mainly intravascular (Fig. 1F ) (results summarized in Table 2 ). Retinal staining for IgG and albumin was absent in the control subjects, except for weak staining for IgG in the photoreceptor layer in most patients (Fig. 1H) . In this study we show that microvascular leakage in the retina of patients with diabetes mellitus, identified by immunohistochemical staining for endogenous fibrinogen, IgG or albumin, is associated with increased expression of the endothelial antigen PAL-E in the retinal microvasculature.
Because of the absence of case histories of most of the donors, our immunohistochemical findings could not be correlated to the clinical degree of diabetic retinopathy or type of diabetes. Where histological evidence of diabetic retinopathy in the studied tissue sections or clinical information on the presence of diabetic retinopathy or other diabetic complications were available, however, these data supported a correlation between the degree of diabetic retinopathy and the immunohistochemical evidence of PAL-E and fibrinogen-positive retinal vessels. In fact, pronounced uniform staining of intraretinal vessels with PAL-E was found in the two patients with known proliferative diabetic retinopathy. The function and molecular characteristics of the PAL-E antigen are not known [13±16] . Still, its tissue distribution and ultrastructural localization are of considerable interest [13±17]. In the brain, eye and testis, the endothelium of vessels constituting a blood-tissue barrier lacks the antigen, whereas permeable capillaries and veins in other organs and in the so-called ªspecial sitesº in the brain, like dura, area postrema and choroid plexus, have pronounced expression [13±17]. In both cultured endothelial cells and in vivo the antigen is specifically localized in pinocytotic plasmalemmal vesicles or caveolae [13, 18] . These organelles play a major part in trans-endothelial transport and are scarce in blood-tissue barrier endothelia [19±22] . In brain tumours, where considerable barrier loss is seen, the endothelial cells have increased numbers of pinocytotic vesicles and substantially increased expression of PAL-E [14, 15] , supporting the association of the PAL-E antigen with trans-endothelial transport via pinocytotic vesicles. The results of this study show a direct correlation between the presence of increased PAL-E expression by barrier endothelial cells and pathological vascular leakage of plasma proteins, lending further support for a role of this antigen in non-specific transendothelial transport. This study also indicates that the PAL-E antigen is useful as a marker for leaky capillaries in eye disease [24] .
In the diabetic eyes studied here, retinal vascular PAL-E expression correlated with staining for endogenous fibrinogen [8, 23] and, in a smaller series of eyes, with vascular and perivascular staining for albumin and IgG. Perivascular staining for fibrinogen in the diabetic rat and human retina has been used previously as an indicator of increased permeability [8, 24] . Surprisingly, we found little or no perivascular staining for fibrinogen in the eyes of diabetic patients, but pronounced staining of the entire capillary wall in contrast with the weak intravascular staining observed in the eyes of control subjects. This pattern could represent structural changes in the microvascular wall and basement membrane in the diabetic eye [2, 3] . Our results indicate that immunohistochemical staining for PAL-E and fibrinogen provides a new and useful means to identify areas affected by diabetic retinopathy in histological sections of human retina [24] .
These findings may have implications for the understanding of the mechanism by which blood-retinal barrier loss occurs in diabetic retinopathy. In view of its specific localization in pinocytotic vesicles, the increased expression in the diabetic retina of the endothelial antigen PAL-E suggests an active role of endothelial cells in the pathogenesis of diabetic retinopathy. This supports the notion that pathological blood-retinal barrier loss in diabetic retinopathy is caused by altered endothelial function. In the normal retina, the blood-retinal barrier is formed by endothelial cells with properties similar to brain endotheli- (correlation coefficient for the two groups combined, gamma = 0.753, p < 0.001) um [27, 28] . The cells have tight junctions, few pinocytotic vesicles and express a number of specific molecules on their surface that are associated with transport of glucose and other nutrients [20, 21, 24, 25, 28] . In many diabetic patients, a diffuse increased permeability of the blood-ocular barriers can be determined by vitreous fluorophotometry, before the development of clinical diabetic retinopathy or visible retinal abnormalities on fluorescein angiography (FA) [1] . In clinical diabetic retinopathy, retina oedema and exudates are observed with characteristic focal or diffuse retinal extravasation of fluorescein on FA [1] . It is not known whether different mechanisms underlie these two types of increased permeability of the blood-ocular barriers in diabetes mellitus. The ªleakageº of retinal vessels may involve opening of the endothelial tight junctions or increased pinocytotic transport [1, 4±6] . As we observed widespread vascular staining for the PAL-E antigen in the retina of 41 % of our diabetic patients, particularly in those with known diabetic retinopathy, this phenotypic shift could be associated primarily with the clinically meaningful second type of ªleakage,º a situation that could well be accompanied by an endothelial dysfunction more severe than in the early preclinical stages.
Our findings are particularly interesting in view of the role of vascular permeability factor/vascular endothelial growth factor (VEGF) in the pathogenesis of diabetic retinopathy [9±12, 29] , as this factor has been shown to enhance vascular permeability in in vivo models [12] and induce increased numbers of endothelial vesicles in vitro [30] and in vivo [31] . VEGF appears to be an important angiogenesis factor in proliferative diabetic retinopathy and neovascularization of the iris [12] . A number of reports suggested that VEGF is also involved in retinal vascular leakage in background diabetic retinopathy in rats and humans [9±11] . A recent paper questioned these results, however, indicating that VEGF protein and its messenger RNA are also present [29] in the normal retina. The relation between PAL-E expression and VEGF will be addressed in further studies.
